PubRank

Shahriar Mobashery

Author PubWeight™ 183.99‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Bacterial resistance to beta-lactam antibiotics: compelling opportunism, compelling opportunity. Chem Rev 2005 4.48
2 Tackling antibiotic resistance. Nat Rev Microbiol 2011 3.95
3 Versatility of aminoglycosides and prospects for their future. Clin Microbiol Rev 2003 3.72
4 Three-dimensional structure of the bacterial cell wall peptidoglycan. Proc Natl Acad Sci U S A 2006 2.81
5 A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia. J Neurosci 2005 2.54
6 Effect of ablation or inhibition of stromal matrix metalloproteinase-9 on lung metastasis in a breast cancer model is dependent on genetic background. Cancer Res 2008 1.88
7 Potent mechanism-based inhibitors for matrix metalloproteinases. J Biol Chem 2005 1.83
8 How allosteric control of Staphylococcus aureus penicillin binding protein 2a enables methicillin resistance and physiological function. Proc Natl Acad Sci U S A 2013 1.75
9 The basis for resistance to beta-lactam antibiotics by penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus. J Biol Chem 2004 1.74
10 Ab initio QM/MM study of class A beta-lactamase acylation: dual participation of Glu166 and Lys73 in a concerted base promotion of Ser70. J Am Chem Soc 2005 1.67
11 Recent advances in MMP inhibitor design. Cancer Metastasis Rev 2006 1.66
12 Bacterial cell-wall recycling. Ann N Y Acad Sci 2012 1.60
13 Molecular basis and phenotype of methicillin resistance in Staphylococcus aureus and insights into new beta-lactams that meet the challenge. Antimicrob Agents Chemother 2009 1.51
14 Design and characterization of a metalloproteinase inhibitor-tethered resin for the detection of active MMPs in biological samples. Chem Biol 2006 1.50
15 Co-opting the cell wall in fighting methicillin-resistant Staphylococcus aureus: potent inhibition of PBP 2a by two anti-MRSA beta-lactam antibiotics. J Am Chem Soc 2008 1.50
16 Cell surface association of matrix metalloproteinase-9 (gelatinase B). Cancer Metastasis Rev 2003 1.45
17 Aminoglycosides modified by resistance enzymes display diminished binding to the bacterial ribosomal aminoacyl-tRNA site. Chem Biol 2002 1.42
18 Resistance to beta-lactam antibiotics and its mediation by the sensor domain of the transmembrane BlaR signaling pathway in Staphylococcus aureus. J Biol Chem 2003 1.38
19 Antimetastatic activity of a novel mechanism-based gelatinase inhibitor. Cancer Res 2005 1.36
20 The future of the β-lactams. Curr Opin Microbiol 2010 1.36
21 High-resolution X-ray structure of an acyl-enzyme species for the class D OXA-10 beta-lactamase. J Am Chem Soc 2002 1.36
22 Synthetic peptidoglycan substrates for penicillin-binding protein 5 of Gram-negative bacteria. J Org Chem 2004 1.33
23 Structural consequences of the inhibitor-resistant Ser130Gly substitution in TEM beta-lactamase. Biochemistry 2005 1.32
24 Inhibition of human prostate cancer growth, osteolysis and angiogenesis in a bone metastasis model by a novel mechanism-based selective gelatinase inhibitor. Int J Cancer 2006 1.32
25 Bacterial AmpD at the crossroads of peptidoglycan recycling and manifestation of antibiotic resistance. J Am Chem Soc 2009 1.31
26 Activation of BlaR1 protein of methicillin-resistant Staphylococcus aureus, its proteolytic processing, and recovery from induction of resistance. J Biol Chem 2011 1.30
27 Mechanistic characterization of the bifunctional aminoglycoside-modifying enzyme AAC(3)-Ib/AAC(6')-Ib' from Pseudomonas aeruginosa. Biochemistry 2007 1.28
28 Mechanistic basis for the emergence of catalytic competence against carbapenem antibiotics by the GES family of beta-lactamases. J Biol Chem 2009 1.28
29 Discoidin domain receptors: unique receptor tyrosine kinases in collagen-mediated signaling. J Biol Chem 2013 1.27
30 Structural insights into the bactericidal mechanism of human peptidoglycan recognition proteins. Proc Natl Acad Sci U S A 2007 1.27
31 Extracellular proteases as targets for treatment of cancer metastases. Chem Soc Rev 2004 1.26
32 Characterization of the bifunctional aminoglycoside-modifying enzyme ANT(3'')-Ii/AAC(6')-IId from Serratia marcescens. Biochemistry 2006 1.25
33 Mechanism of anchoring of OmpA protein to the cell wall peptidoglycan of the gram-negative bacterial outer membrane. FASEB J 2011 1.25
34 Mutational replacement of Leu-293 in the class C Enterobacter cloacae P99 beta-lactamase confers increased MIC of cefepime. Antimicrob Agents Chemother 2002 1.23
35 Design of novel antibiotics that bind to the ribosomal acyltransfer site. J Am Chem Soc 2002 1.23
36 The importance of a critical protonation state and the fate of the catalytic steps in class A beta-lactamases and penicillin-binding proteins. J Biol Chem 2004 1.22
37 Activation for catalysis of penicillin-binding protein 2a from methicillin-resistant Staphylococcus aureus by bacterial cell wall. J Am Chem Soc 2005 1.22
38 Reactions of all Escherichia coli lytic transglycosylases with bacterial cell wall. J Am Chem Soc 2013 1.21
39 Source of phosphate in the enzymic reaction as a point of distinction among aminoglycoside 2''-phosphotransferases. J Biol Chem 2009 1.21
40 Lytic transglycosylase MltB of Escherichia coli and its role in recycling of peptidoglycan strands of bacterial cell wall. J Am Chem Soc 2008 1.21
41 Synthesis of a fragment of bacterial cell wall. J Org Chem 2004 1.20
42 Total synthesis of N-acetylglucosamine-1,6-anhydro-N-acetylmuramylpentapeptide and evaluation of its turnover by AmpD from Escherichia coli. J Am Chem Soc 2009 1.19
43 Molecular structures and dynamics of the stepwise activation mechanism of a matrix metalloproteinase zymogen: challenging the cysteine switch dogma. J Am Chem Soc 2007 1.19
44 The complex of a designer antibiotic with a model aminoacyl site of the 30S ribosomal subunit revealed by X-ray crystallography. J Am Chem Soc 2003 1.18
45 Discrete steps in sensing of beta-lactam antibiotics by the BlaR1 protein of the methicillin-resistant Staphylococcus aureus bacterium. Proc Natl Acad Sci U S A 2006 1.17
46 Messenger functions of the bacterial cell wall-derived muropeptides. Biochemistry 2012 1.17
47 Three decades of the class A beta-lactamase acyl-enzyme. Curr Protein Pept Sci 2009 1.17
48 X-ray crystal structure of the acylated beta-lactam sensor domain of BlaR1 from Staphylococcus aureus and the mechanism of receptor activation for signal transduction. J Am Chem Soc 2004 1.15
49 Synthetic peptidoglycan motifs for germination of bacterial spores. Chembiochem 2010 1.12
50 Complex pattern of membrane type 1 matrix metalloproteinase shedding. Regulation by autocatalytic cells surface inactivation of active enzyme. J Biol Chem 2002 1.12
51 Disruption of allosteric response as an unprecedented mechanism of resistance to antibiotics. J Am Chem Soc 2014 1.11
52 Active site ring-opening of a thiirane moiety and picomolar inhibition of gelatinases. Chem Biol Drug Des 2009 1.11
53 Roles of matrix metalloproteinases in flow-induced outward vascular remodeling. J Cereb Blood Flow Metab 2009 1.10
54 Metabolism of a highly selective gelatinase inhibitor generates active metabolite. Chem Biol Drug Des 2007 1.10
55 Discovery of a new class of non-β-lactam inhibitors of penicillin-binding proteins with Gram-positive antibacterial activity. J Am Chem Soc 2014 1.10
56 Pharmacological stabilization of intracranial aneurysms in mice: a feasibility study. Stroke 2012 1.10
57 Inhibition of MMP-9 by a selective gelatinase inhibitor protects neurovasculature from embolic focal cerebral ischemia. Mol Neurodegener 2012 1.10
58 Prostate cancer-associated membrane type 1-matrix metalloproteinase: a pivotal role in bone response and intraosseous tumor growth. Am J Pathol 2007 1.09
59 Insertion of epicatechin gallate into the cytoplasmic membrane of methicillin-resistant Staphylococcus aureus disrupts penicillin-binding protein (PBP) 2a-mediated beta-lactam resistance by delocalizing PBP2. J Biol Chem 2010 1.09
60 Short alkylated peptoid mimics of antimicrobial lipopeptides. Antimicrob Agents Chemother 2010 1.08
61 Synthesis of chiral 2-(4-phenoxyphenylsulfonylmethyl)thiiranes as selective gelatinase inhibitors. Org Lett 2005 1.08
62 Molecular dynamics at the root of expansion of function in the M69L inhibitor-resistant TEM beta-lactamase from Escherichia coli. J Am Chem Soc 2002 1.08
63 Structural basis for carbapenemase activity of the OXA-23 β-lactamase from Acinetobacter baumannii. Chem Biol 2013 1.08
64 Pronounced diversity in electronic and chemical properties between the catalytic zinc sites of tumor necrosis factor-alpha-converting enzyme and matrix metalloproteinases despite their high structural similarity. J Biol Chem 2004 1.07
65 A practical synthesis of nitrocefin. J Org Chem 2005 1.07
66 Reactions of the three AmpD enzymes of Pseudomonas aeruginosa. J Am Chem Soc 2013 1.06
67 Elucidation of the molecular recognition of bacterial cell wall by modular pneumococcal phage endolysin CPL-1. J Biol Chem 2007 1.06
68 Crystal structures of penicillin-binding protein 6 from Escherichia coli. J Am Chem Soc 2009 1.05
69 Design, synthesis, and characterization of potent, slow-binding inhibitors that are selective for gelatinases. J Biol Chem 2002 1.04
70 Matrix metalloproteinase 2 inhibition: combined quantum mechanics and molecular mechanics studies of the inhibition mechanism of (4-phenoxyphenylsulfonyl)methylthiirane and its oxirane analogue. Biochemistry 2009 1.04
71 Lysine N(zeta)-decarboxylation in the BlaR1 protein from Staphylococcus aureus at the root of its function as an antibiotic sensor. J Am Chem Soc 2007 1.03
72 Phosphoryl transfer by aminoglycoside 3'-phosphotransferases and manifestation of antibiotic resistance. Bioorg Chem 2004 1.03
73 Kinetic mechanism of enterococcal aminoglycoside phosphotransferase 2"-Ib. Biochemistry 2007 1.02
74 Effect of synthetic matrix metalloproteinase inhibitors on lipopolysaccharide-induced blood-brain barrier opening in rodents: Differences in response based on strains and solvents. Brain Res 2006 1.02
75 Catalytic mechanism of penicillin-binding protein 5 of Escherichia coli. Biochemistry 2007 1.02
76 Insights into pneumococcal fratricide from the crystal structures of the modular killing factor LytC. Nat Struct Mol Biol 2010 1.01
77 A potent gelatinase inhibitor with anti-tumor-invasive activity and its metabolic disposition. Chem Biol Drug Des 2009 1.00
78 Crystal structures of bacterial peptidoglycan amidase AmpD and an unprecedented activation mechanism. J Biol Chem 2011 1.00
79 Shedding of discoidin domain receptor 1 by membrane-type matrix metalloproteinases. J Biol Chem 2013 1.00
80 Mechanistic basis for the action of new cephalosporin antibiotics effective against methicillin- and vancomycin-resistant Staphylococcus aureus. J Biol Chem 2006 1.00
81 Resistance to the third-generation cephalosporin ceftazidime by a deacylation-deficient mutant of the TEM β-lactamase by the uncommon covalent-trapping mechanism. Biochemistry 2011 1.00
82 Crystal structure of CbpF, a bifunctional choline-binding protein and autolysis regulator from Streptococcus pneumoniae. EMBO Rep 2009 0.99
83 Investigation of the mechanism of the cell wall DD-carboxypeptidase reaction of penicillin-binding protein 5 of Escherichia coli by quantum mechanics/molecular mechanics calculations. J Am Chem Soc 2008 0.98
84 Interactions of designer antibiotics and the bacterial ribosomal aminoacyl-tRNA site. Chem Biol 2006 0.98
85 Selective inhibition of matrix metalloproteinase-9 attenuates secondary damage resulting from severe traumatic brain injury. PLoS One 2013 0.98
86 Quest for selectivity in inhibition of matrix metalloproteinases. Curr Top Med Chem 2004 0.97
87 Structural basis for potent slow binding inhibition of human matrix metalloproteinase-2 (MMP-2). J Biol Chem 2003 0.97
88 Dissection of events in the resistance to β-lactam antibiotics mediated by the protein BlaR1 from Staphylococcus aureus. Biochemistry 2012 0.97
89 The bifunctional enzymes of antibiotic resistance. Curr Opin Microbiol 2009 0.96
90 Design, synthesis, and evaluation of a mechanism-based inhibitor for gelatinase A. J Org Chem 2005 0.96
91 Recognition of peptidoglycan and β-lactam antibiotics by the extracellular domain of the Ser/Thr protein kinase StkP from Streptococcus pneumoniae. FEBS Lett 2010 0.96
92 A computational evaluation of the mechanism of penicillin-binding protein-catalyzed cross-linking of the bacterial cell wall. J Am Chem Soc 2011 0.96
93 Lysine Nzeta-decarboxylation switch and activation of the beta-lactam sensor domain of BlaR1 protein of methicillin-resistant Staphylococcus aureus. J Biol Chem 2011 0.96
94 Structural aspects for evolution of beta-lactamases from penicillin-binding proteins. J Am Chem Soc 2003 0.95
95 Selective water-soluble gelatinase inhibitor prodrugs. J Med Chem 2011 0.95
96 Binding of the gene repressor BlaI to the bla operon in methicillin-resistant Staphylococcus aureus. Biochemistry 2010 0.95
97 Hydrolysis of ATP by aminoglycoside 3'-phosphotransferases: an unexpected cost to bacteria for harboring an antibiotic resistance enzyme. J Biol Chem 2006 0.94
98 Metabolism of (4-phenoxyphenylsulfonyl) methylthiirane, a selective gelatinase inhibitor. Chem Biol Drug Des 2008 0.94
99 Shared functional attributes between the mecA gene product of Staphylococcus sciuri and penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus. Biochemistry 2007 0.93
100 Restoration of susceptibility of methicillin-resistant Staphylococcus aureus to beta-lactam antibiotics by acidic pH: role of penicillin-binding protein PBP 2a. J Biol Chem 2008 0.93
101 Penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus. IUBMB Life 2014 0.93
102 Testosterone-induced matrix metalloproteinase activation is a checkpoint for neuronal addition to the adult songbird brain. J Neurosci 2008 0.92
103 Selective gelatinase inhibitor neuroprotective agents cross the blood-brain barrier. ACS Chem Neurosci 2012 0.92
104 A mechanism-based inhibitor targeting the DD-transpeptidase activity of bacterial penicillin-binding proteins. J Am Chem Soc 2003 0.92
105 DFT studies of the ring-opening mechanism of SB-3CT, a potent inhibitor of matrix metalloproteinase 2. Org Lett 2009 0.92
106 An antibiotic-resistance enzyme from a deep-sea bacterium. J Am Chem Soc 2010 0.91
107 Cell-wall remodeling by the zinc-protease AmpDh3 from Pseudomonas aeruginosa. J Am Chem Soc 2013 0.91
108 Identification of products of inhibition of GES-2 beta-lactamase by tazobactam by x-ray crystallography and spectrometry. J Biol Chem 2011 0.91
109 A convenient synthesis of a selective gelatinase inhibitor as an antimetastatic agent. J Org Chem 2004 0.91
110 Discovery of antibiotic (E)-3-(3-carboxyphenyl)-2-(4-cyanostyryl)quinazolin-4(3H)-one. J Am Chem Soc 2015 0.90
111 High-resolution crystal structure of MltE, an outer membrane-anchored endolytic peptidoglycan lytic transglycosylase from Escherichia coli. Biochemistry 2011 0.90
112 Structure-activity relationship for the oxadiazole class of antibiotics. J Med Chem 2015 0.90
113 Aminoglycoside 2''-phosphotransferase type IIIa from Enterococcus. J Biol Chem 2008 0.90
114 Structural and functional insights into peptidoglycan access for the lytic amidase LytA of Streptococcus pneumoniae. MBio 2014 0.90
115 Characterization of the beta-lactam antibiotic sensor domain of the MecR1 signal sensor/transducer protein from methicillin-resistant Staphylococcus aureus. Biochemistry 2007 0.89
116 A dynamic structure for the acyl-enzyme species of the antibiotic aztreonam with the Citrobacter freundii beta-lactamase revealed by infrared spectroscopy and molecular dynamics simulations. Biochemistry 2003 0.89
117 Mechanism-based profiling of MMPs. Methods Mol Biol 2010 0.88
118 Fluorinated aminoglycosides and their mechanistic implication for aminoglycoside 3'-phosphotransferases from Gram-negative bacteria. Biochemistry 2004 0.88
119 Synthesis, kinetic characterization and metabolism of diastereomeric 2-(1-(4-phenoxyphenylsulfonyl)ethyl)thiiranes as potent gelatinase and MT1-MMP inhibitors. Chem Biol Drug Des 2009 0.88
120 Conformational transition in the aminoacyl t-RNA site of the bacterial ribosome both in the presence and absence of an aminoglycoside antibiotic. Chem Biol Drug Des 2007 0.88
121 Lysine carboxylation in proteins: OXA-10 beta-lactamase. Proteins 2005 0.88
122 A novel beta-lactamase activity from a penicillin-binding protein of Treponema pallidum and why syphilis is still treatable with penicillin. J Biol Chem 2004 0.88
123 Cleavage at the stem region releases an active ectodomain of the membrane type 1 matrix metalloproteinase. Biochem J 2005 0.87
124 Thermodynamics of interactions of vancomycin and synthetic surrogates of bacterial cell wall. J Am Chem Soc 2006 0.87
125 Regulation of the expression of the β-lactam antibiotic-resistance determinants in methicillin-resistant Staphylococcus aureus (MRSA). Biochemistry 2014 0.87
126 Endogenous matrix metalloproteinases 2 and 9 regulate activation of CD4+ and CD8+ T cells. Am J Respir Cell Mol Biol 2010 0.87
127 Mutational and structural analyses of the hinge region of membrane type 1-matrix metalloproteinase and enzyme processing. J Biol Chem 2005 0.86
128 Identification and role of the homodimerization interface of the glycosylphosphatidylinositol-anchored membrane type 6 matrix metalloproteinase (MMP25). J Biol Chem 2008 0.86
129 Catalytic spectrum of the penicillin-binding protein 4 of Pseudomonas aeruginosa, a nexus for the induction of β-lactam antibiotic resistance. J Am Chem Soc 2014 0.86
130 Design and synthesis of a structurally constrained aminoglycoside. J Org Chem 2007 0.85
131 An amino acid position at crossroads of evolution of protein function: antibiotic sensor domain of BlaR1 protein from Staphylococcus aureus versus clasS D β-lactamases. J Biol Chem 2012 0.84
132 Matrix metalloproteinase 2 (MMP2) inhibition: DFT and QM/MM studies of the deprotonation-initialized ring-opening reaction of the sulfoxide analogue of SB-3CT. J Phys Chem B 2010 0.84
133 N-Glycosylation pattern of the zymogenic form of human matrix metalloproteinase-9. Bioorg Chem 2002 0.84
134 Structural analysis of the role of Pseudomonas aeruginosa penicillin-binding protein 5 in β-lactam resistance. Antimicrob Agents Chemother 2013 0.83
135 Structure and cell wall cleavage by modular lytic transglycosylase MltC of Escherichia coli. ACS Chem Biol 2014 0.83
136 Conformational analyses of thiirane-based gelatinase inhibitors. Bioorg Med Chem Lett 2007 0.82
137 Structural basis for progression toward the carbapenemase activity in the GES family of β-lactamases. J Am Chem Soc 2012 0.82
138 Host-guest chemistry of the peptidoglycan. J Med Chem 2010 0.82
139 Inhibitors for Bacterial Cell-Wall Recycling. ACS Med Chem Lett 2012 0.82
140 Complications from dual roles of sodium hydride as a base and as a reducing agent. J Org Chem 2009 0.82
141 Why clinically used tazobactam and sulbactam are poor inhibitors of OXA-10 beta-lactamase: Raman crystallographic evidence. Biochemistry 2008 0.82
142 MT1-MMP shedding involves an ADAM and is independent of its localization in lipid rafts. Biochem Biophys Res Commun 2006 0.81
143 Synthesis and NMR characterization of (Z,Z,Z,Z,E,E,ω)-heptaprenol. J Am Chem Soc 2012 0.81
144 Computational investigation of irreversible inactivation of the zinc-dependent protease carboxypeptidase A. J Phys Chem B 2005 0.81
145 A chemical biological strategy to facilitate diabetic wound healing. ACS Chem Biol 2013 0.81
146 Revealing cell-surface intramolecular interactions in the BlaR1 protein of methicillin-resistant Staphylococcus aureus by NMR spectroscopy. Biochemistry 2013 0.81
147 Elucidation of the structure of the membrane anchor of penicillin-binding protein 5 of Escherichia coli. J Am Chem Soc 2010 0.81
148 Facile preparation of a highly functionalized tetrahydropyran by catalytic hydrogenation of an oxazoline. J Org Chem 2008 0.81
149 Strategy in inhibition of cathepsin B, a target in tumor invasion and metastasis. J Am Chem Soc 2004 0.81
150 Synthesis of an inhibitor-tethered resin for detection of active matrix metalloproteinases involved in disease. J Org Chem 2006 0.80
151 Characterization of the dimerization interface of membrane type 4 (MT4)-matrix metalloproteinase. J Biol Chem 2011 0.80
152 Regiospecific syntheses of 6alpha-(1R-Hydroxyoctyl)penicillanic acid and 6beta-(1R-hydroxyoctyl)penicillanic acid as mechanistic probes of class D beta-lactamases. Org Lett 2009 0.79
153 Structure-Activity Relationship for Thiirane-Based Gelatinase Inhibitors. ACS Med Chem Lett 2012 0.79
154 Sulfonylation-induced N- to O-acetyl migration in 2-acetamidoethanol derivatives. J Org Chem 2010 0.78
155 The X-ray structure of carboxypeptidase A inhibited by a thiirane mechanism-based inhibitor. Chem Biol Drug Des 2009 0.78
156 QM/MM Studies of the Matrix Metalloproteinase 2 (MMP2) Inhibition Mechanism of (S)-SB-3CT and its Oxirane Analogue. J Chem Theory Comput 2010 0.78
157 O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier. J Med Chem 2013 0.78
158 Glycosylation at Asn211 regulates the activation state of the discoidin domain receptor 1 (DDR1). J Biol Chem 2014 0.78
159 Investigation of signal transduction routes within the sensor/transducer protein BlaR1 of Staphylococcus aureus. Biochemistry 2015 0.78
160 Protonation states of active-site lysines of penicillin-binding protein 6 from Escherichia coli and the mechanistic implications. Proteins 2014 0.78
161 Antibiotics as physiological stress inducers and bacterial response to the challenge. Curr Opin Microbiol 2012 0.76
162 Cytoplasmic-membrane anchoring of a class A beta-lactamase and its capacity in manifesting antibiotic resistance. Antimicrob Agents Chemother 2007 0.76
163 Water-Soluble MMP-9 Inhibitor Reduces Lesion Volume after Severe Traumatic Brain Injury. ACS Chem Neurosci 2015 0.76
164 Crystallization and preliminary X-ray diffraction analysis of the lytic transglycosylase MltE from Escherichia coli. Acta Crystallogr Sect F Struct Biol Cryst Commun 2010 0.75
165 Use of silver carbonate in the Wittig reaction. J Org Chem 2013 0.75
166 The Allosteric Site for the Nascent Cell Wall in Penicillin-Binding Protein 2a: An Achilles' Heel of Methicillin-Resistant Staphylococcus aureus. Curr Med Chem 2015 0.75
167 Exploration of mild copper-mediated coupling of organotrifluoroborates in the synthesis of thiirane-based inhibitors of matrix metalloproteinases. Bioorg Med Chem Lett 2010 0.75
168 Prospects of therapies targeting resistant bacteria-New challenges 20 years post emergence of vancomycin-resistant enterococcus. Curr Opin Microbiol 2007 0.75
169 The X-ray Structure of Catenated Lytic Transglycosylase SltB1. Biochemistry 2017 0.75
170 Complex biological processes and their central chemical events. Curr Opin Chem Biol 2003 0.75
171 Corrigendum: Muropeptides in Pseudomonas aeruginosa and their Role as Elicitors of β-Lactam-Antibiotic Resistance. Angew Chem Int Ed Engl 2016 0.75
172 Turnover of Bacterial Cell Wall by SltB3, a Multidomain Lytic Transglycosylase of Pseudomonas aeruginosa. ACS Chem Biol 2016 0.75
173 Whole-Genome Shotgun Sequencing of Two β-Proteobacterial Species in Search of the Bulgecin Biosynthetic Cluster. ACS Chem Biol 2017 0.75
174 Side reaction of significance in preparation of peptide- or peptidomimetic-based hydroxamate enzyme inhibitors. J Org Chem 2006 0.75